TET2 and breast cancer: We thus chose to ectopically express TET2 in breast cancer cells and transfected MCF-7 cells with an expression vector for the Flag-tagged active murine TET2 CD and as controls, with a catalytically dead mutant (H1304Y and D1306A) TET2 mCD (18) or an empty vector (EV).